Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Trinseo PLCTSE · Entity 8671 | SVP & Business President | February 26, 2019 | March 01, 2019 |
| Xylem Inc.XYL · Entity 430 | EVP & President, WI | March 05, 2026 | March 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Trinseo PLC
Report date February 26, 2019 · Filed March 01, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 25,589 |
Reported balance
After 2019-02-26 transaction · row 1
1 source rowRow 1 · 2019-02-26 · Grant · Acquired 3,836 · Balance 25,589 F1: Represents ordinary shares issuable pursuant to RSU award that will vest in full on the third anniversary of the grant date. |
| Option to Purchase Ordinary SharesSEC Table II · derivative / convertible security · Conversion / exercise price $51.02 · Expires 2028-02-26 | Direct | 52,524 |
Reported balance
After 2019-02-26 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-02-26 · Grant · Acquired 12,702 · Balance 52,524 F2: The option vests in three equal annual installments beginning on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents ordinary shares issuable pursuant to RSU award that will vest in full on the third anniversary of the grant date.
F2: The option vests in three equal annual installments beginning on the first anniversary of the grant date.
Xylem Inc.
Report date March 05, 2026 · Filed March 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,540 |
Reported balance
After 2026-03-05 transaction · row 1
1 source rowRow 1 · 2026-03-05 · Tax withholding · Disposed 41 · Balance 33,540 F1: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 5, 2025 (41) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 5, 2025 (41) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 05, 2026 Filed Mar 6, 2026 21:22 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 41 | $126.19 | $5,173.79 |
DisclosureSEC source: 0001524472-26-000059 · form4.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · EVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,540 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 5, 2025 (41) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:44 UTC | Xylem Inc. XYL · Entity 430 | GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 8,102 | $128.98 Strike: $128.98 | $1,044,995.96 |
DisclosureSEC source: 0001524472-26-000033 · form4.xml · derivative · entry 9 Yarkadas Hayati · CIK 0001657363 · EVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,102 Underlying: Common Stock · 8,102 shares Expires 2036-03-02 F10 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:44 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 117 | $128.98 | $15,090.66 |
DisclosureSEC source: 0001524472-26-000033 · form4.xml · nonDerivative · entry 8 Yarkadas Hayati · CIK 0001657363 · EVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,581 F9 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (75) and March 1, 2024 (42) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:44 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 94 | $128.98 | $12,124.12 |
DisclosureSEC source: 0001524472-26-000033 · form4.xml · nonDerivative · entry 7 Yarkadas Hayati · CIK 0001657363 · EVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,698 F8 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:44 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 565 | $128.98 | $72,873.70 |
DisclosureSEC source: 0001524472-26-000033 · form4.xml · nonDerivative · entry 6 Yarkadas Hayati · CIK 0001657363 · EVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,792 F7 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:44 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 2,274 | $0.00 | $0.00 |
DisclosureSEC source: 0001524472-26-000033 · form4.xml · nonDerivative · entry 5 Yarkadas Hayati · CIK 0001657363 · EVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,357 F6 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:44 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 1,761 | $128.98 | $227,133.78 |
DisclosureSEC source: 0001524472-26-000033 · form4.xml · nonDerivative · entry 4 Yarkadas Hayati · CIK 0001657363 · EVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,083 F5 · shares: Reflects the acquisition of 1,761 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:44 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 2,501 | $128.98 | $322,578.98 |
DisclosureSEC source: 0001524472-26-000033 · form4.xml · nonDerivative · entry 3 Yarkadas Hayati · CIK 0001657363 · EVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,322 F4 · shares: Reflects the acquisition of 2,501 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:44 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 3,679 | $128.98 | $474,517.42 |
DisclosureSEC source: 0001524472-26-000033 · form4.xml · nonDerivative · entry 2 Yarkadas Hayati · CIK 0001657363 · EVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,821 F3 · shares: Reflects the acquisition of 3,679 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:44 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 4,456 | $128.98 | $574,734.88 |
DisclosureSEC source: 0001524472-26-000033 · form4.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · EVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,142 F1 · shares: Reflects the acquisition of 4,456 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 05, 2025 Filed Mar 6, 2025 21:13 UTC | Xylem Inc. XYL · Entity 430 | GrantNon-Qualified Stock Options (Right to buy) · Derivative | 8,119 | $129.67 Strike: $129.67 | $1,052,790.73 |
DisclosureSEC source: 0001562180-25-002152 · primarydocument.xml · derivative · entry 2 Yarkadas Hayati · CIK 0001657363 · SVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,119 Underlying: Common Stock · 8,119 shares Expires 2035-03-05 F2 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027 and March 5, 2028. Read SEC document |
| March 05, 2025 Filed Mar 6, 2025 21:13 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 2,314 | $129.67 | $300,056.38 |
DisclosureSEC source: 0001562180-25-002152 · primarydocument.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · SVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,616 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 5, 2026, March 5, 2027 and March 5, 2028. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:14 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 179 | $129.78 | $23,230.62 |
DisclosureSEC source: 0001562180-25-001970 · primarydocument.xml · nonDerivative · entry 5 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,302 F6 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2022 (62), March 1, 2023 (75), and March 1, 2024 (42) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:14 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 456 | $129.78 | $59,179.68 |
DisclosureSEC source: 0001562180-25-001970 · primarydocument.xml · nonDerivative · entry 4 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,481 F5 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2022 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:14 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 3,026 | $129.78 | $392,714.28 |
DisclosureSEC source: 0001562180-25-001970 · primarydocument.xml · nonDerivative · entry 3 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,937 F4 · shares: Reflects the acquisition of 3,026 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:14 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 3,026 | $129.78 | $392,714.28 |
DisclosureSEC source: 0001562180-25-001970 · primarydocument.xml · nonDerivative · entry 2 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,911 F3 · shares: Reflects the acquisition of 3,026 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ROIC. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:14 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 2,524 | $129.78 | $327,564.72 |
DisclosureSEC source: 0001562180-25-001970 · primarydocument.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,885 F1 · shares: Reflects the acquisition of 2,524 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 05, 2024 Filed Mar 5, 2024 22:09 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 4,547 | $127.53 | $579,878.91 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 10 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,353 F5 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $127.10 to $127.55. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC | Xylem Inc. XYL · Entity 430 | GrantStock Options (Right to buy) · Derivative | 7,932 | $127.94 Strike: $127.94 | $1,014,820.08 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · derivative · entry 14 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,932 Underlying: Common Stock · 7,932 shares Expires 2034-03-01 F9 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2025, March 1, 2026 and March 1, 2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,035 | $0.00 Strike: $86.76 | $0.00 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · derivative · entry 13 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,036 Underlying: Common Stock · 5,035 shares Expires 2032-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The March 1, 2022 option grant vested 5,035 options on March 1, 2023, 5,035 options on March 1, 2024, and will vest 5,036 options on March 1, 2025. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 4,875 | $0.00 Strike: $101.09 | $0.00 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · derivative · entry 12 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,750 Underlying: Common Stock · 4,875 shares Expires 2033-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The March 1, 2023 option grant vested 4,875 options on March 1, 2024, and will vest 4,875 options on March 1, 2025, and 4,875 options on March 1, 2026. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 9,698 | $0.00 Strike: $102.23 | $0.00 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · derivative · entry 11 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,698 shares Expires 2031-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The March 1, 2021 option grant vested 3,201 options on March 1, 2022, 3,265 options on March 1,2023, and 3,232 options on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 4,875 | $127.17 | $619,953.75 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 9 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,900 F4 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $127.03 to $127.30. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionCommon Stock | 4,875 | $101.09 | $492,813.75 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 8 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 4,870 | $127.14 | $619,171.80 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 7 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,900 F4 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $127.03 to $127.30. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 5,035 | $127.14 | $640,149.90 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 6 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,770 F4 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $127.03 to $127.30. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionCommon Stock | 5,035 | $86.76 | $436,836.60 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 5 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 9,698 | $127.14 | $1,233,003.72 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 4 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,770 F4 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $127.03 to $127.30. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionCommon Stock | 9,698 | $102.23 | $991,426.54 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 3 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 428 | $127.94 | $54,758.32 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 2 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,770 F3 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2021 (252) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 (39), March 1, 2022 (62), and March 1, 2023 (75) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 7,084 | $127.94 | $906,326.96 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,198 F1 · shares: Reflects the acquisition of 4,739 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ROIC (2,934) and Total Shareholder Return (1,805). Reflects an award of 2,345 restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016) that are scheduled to vest in one third increments on March 1, 2025, March 1, 2026 and March 1, 2027. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| May 07, 2023 Filed May 9, 2023 22:02 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 71 | $108.97 | $7,736.87 |
DisclosureSEC source: 0001562180-23-004018 · primarydocument.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,075 F1 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on May 7, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 00:13 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,076 | $0.00 Strike: $63.55 | $0.00 |
DisclosureSEC source: 0001562180-23-002451 · primarydocument.xml · derivative · entry 8 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,076 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The March 1, 2022 option grant vested one-third on March 1, 2023, and will vest one-third on each of March 1, 2024 and March 1, 2025. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 00:13 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,035 | $0.00 Strike: $86.76 | $0.00 |
DisclosureSEC source: 0001562180-23-002451 · primarydocument.xml · derivative · entry 7 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,035 shares Expires 2032-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The May 7, 2020 option grant vested in one-third increments on February 27, 2021, February 27, 2022 and February 27, 2023. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 00:13 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 15,942 | $100.43 | $1,601,008.83 |
DisclosureSEC source: 0001562180-23-002451 · primarydocument.xml · nonDerivative · entry 5 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,146 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.27 to $100.64, inclusive. The reporting person undertakes to provide to Xylem, Inc., any security holder of Xylem, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in Footnote 3 to this Form 4. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 00:13 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionCommon Stock | 5,035 | $86.79 | $436,987.65 |
DisclosureSEC source: 0001562180-23-002451 · primarydocument.xml · nonDerivative · entry 4 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 00:13 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionCommon Stock | 6,076 | $63.55 | $386,129.80 |
DisclosureSEC source: 0001562180-23-002451 · primarydocument.xml · nonDerivative · entry 3 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,053 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:13 UTC | Xylem Inc. XYL · Entity 430 | GrantStock Option (Right to Buy) · Derivative | 14,625 | $101.09 Strike: $101.09 | $1,478,441.25 |
DisclosureSEC source: 0001562180-23-002451 · primarydocument.xml · derivative · entry 6 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,625 Underlying: Common Stock · 14,625 shares Expires 2033-03-01 F4 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2024, March 1, 2025 and March 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:13 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 4,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-002451 · primarydocument.xml · nonDerivative · entry 2 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,977 F2 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2024, March 1, 2025 and March 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:13 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 102 | $101.09 | $10,311.18 |
DisclosureSEC source: 0001562180-23-002451 · primarydocument.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,773 F1 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 (40) and March 1, 2022 (62) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:31 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 64 | $102.55 | $6,563.20 |
DisclosureSEC source: 0001562180-23-002020 · primarydocument.xml · nonDerivative · entry 3 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,875 F3 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on May 7, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:31 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 306 | $102.55 | $31,380.30 |
DisclosureSEC source: 0001562180-23-002020 · primarydocument.xml · nonDerivative · entry 2 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,939 F2 · shares: Reflects units withheld to pay the tax liability incident to the vesting of performance-based restricted stock units granted on May 7, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:31 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 5,772 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-002020 · primarydocument.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,245 F1 · shares: Reflects shares of common stock earned upon vesting of performance-based restricted stock units granted May 7, 2020 upon achievement of performance criteria related to Total Shareholder Return. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:58 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 2,083 | $106.94 | $222,756.02 |
DisclosureSEC source: 0001562180-23-001517 · primarydocument.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,473 Read SEC document |
| June 27, 2022 Filed Jun 29, 2022 20:04 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,898 | $0.00 Strike: $63.55 | $0.00 |
DisclosureSEC source: 0001209191-22-039773 · doc4.xml · derivative · entry 3 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,076 Underlying: Common Stock · 5,898 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The May 7, 2020 option grant vests in one third increments on February 27, 2021, February 27, 2022 and February 27, 2023. Read SEC document |
| June 27, 2022 Filed Jun 29, 2022 20:04 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 5,898 | $80.06 | $472,212.16 |
DisclosureSEC source: 0001209191-22-039773 · doc4.xml · nonDerivative · entry 2 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,556 F1 · shares: The exercise and sale was made pursuant to a 10b5-1 plan adopted by the reporting person on May 19, 2022. F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were sold at a range of prices from $80.00 to $80.31. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| June 27, 2022 Filed Jun 29, 2022 20:04 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionCommon Stock | 5,898 | $63.55 | $374,817.90 |
DisclosureSEC source: 0001209191-22-039773 · doc4.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise and sale was made pursuant to a 10b5-1 plan adopted by the reporting person on May 19, 2022. Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 20:06 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 2,082 | $74.18 | $154,436.10 |
DisclosureSEC source: 0001209191-22-038668 · doc4.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,556 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on May 19, 2022. F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,600 shares were sold at a range of prices from $73.78 to $74.62. 482 shares were sold at a range of prices from $74.80 to $74.84. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| May 09, 2022 Filed May 10, 2022 21:45 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 75 | $86.37 | $6,477.75 |
DisclosureSEC source: 0001209191-22-028122 · doc4.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,638 F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on May 7, 2020 under the Xylem 2011 Omnibus Incentive Plan F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 22:03 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 43 | $87.87 | $3,778.41 |
DisclosureSEC source: 0001209191-22-015605 · doc4.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,255 F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.